Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Adv Drug Deliv Rev ; 56(1): 77-94, 2004 Jan 13.
Article in English | MEDLINE | ID: mdl-14706446

ABSTRACT

Photodynamic therapy (PDT) is a tool for the treatment of certain cancerous and pre-cancerous conditions in dermatology. 5-Aminolevulinic acid (5-ALA) and simple derivatives thereof are the principal compounds used for this purpose. For optimal efficacy, the drug must be released at an appropriate rate from the formulation and penetrate the skin, ideally to reach the target tissue at a sufficiently high concentration. Because ALA is a polar, zwitterionic compound, its formulation in conventional topical vehicles, and its inherently poor skin permeability, poses important challenges for the pharmaceutical scientist. The synthesis of more lipophilic (e.g. ester) prodrugs of ALA resolves, in part, these issues but then demands that questions, related to biotransformation back to the parent 5-ALA and to stability, be addressed. The objective of this review, therefore, is to evaluate the state-of-the-art and identify those areas in which additional research is necessary.


Subject(s)
Aminolevulinic Acid , Drug Delivery Systems/methods , Photochemotherapy/methods , Photosensitizing Agents , Skin Neoplasms/drug therapy , Aminolevulinic Acid/administration & dosage , Aminolevulinic Acid/analogs & derivatives , Aminolevulinic Acid/therapeutic use , Chemistry, Pharmaceutical , Humans , Photosensitizing Agents/administration & dosage , Photosensitizing Agents/chemistry , Photosensitizing Agents/therapeutic use , Structure-Activity Relationship
2.
Pharm Res ; 21(12): 2247-52, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15648256

ABSTRACT

PURPOSE: In topical photodynamic therapy, 5-ALA and its esters are enzymatically converted in the endogenous photosensitizing compounds such as, for example, protoporphyrin IX (PpIX). In order to elucidate in more detail their enzymatic fate, we have determined in vitro the enzymatic degradation of methyl, butyl, hexyl, and octyl-5-ALA ester derivatives in skin homogenate. Furthermore, in vivo porphyrin accumulation was measured in healthy hairless mice skins. METHODS: Hairless mouse skins were homogenized in isotonic phosphate buffer pH 7.4. 5-ALA esters were added, and aliquots were colleted for HPLC-fluorimetric determinations of remaining content of 5-ALA esters. Furthermore, oil-in-water emulsions containing esters were topically applied to mice skin for 6 h, and the amount of accumulated PpIX in the treated areas was determined by quantitative extraction and confocal fluorescence microscopy. RESULTS: The enzymatic degradation of esters follows pseudo first-order kinetics. The octyl ester had the largest rate constant for enzymatic degradation, followed by hexyl-, butyl-, and methyl-ALA. The long-chained 5-ALA esters, butyl-, hexyl-, and octyl ester, induced significantly more porphyrins than 5-ALA and 5-ALA methyl ester as shown by confocal microscopy and quantitative extraction studies. CONCLUSIONS: 5-ALA derivatives differ widely with respect to their enzymatic degradation. The presence of alkyl chains in 5-ALA esters significantly influences the in vitro enzymatic metabolism and the in vivo PpIX formation in healthy hairless mice skins.


Subject(s)
Aminolevulinic Acid/chemistry , Aminolevulinic Acid/metabolism , Protoporphyrins/metabolism , Skin/metabolism , Aminolevulinic Acid/analysis , Animals , Esters , Male , Mice , Mice, Hairless , Photosensitizing Agents/metabolism , Protoporphyrins/analysis , Skin/chemistry
3.
J Control Release ; 89(2): 261-9, 2003 Apr 29.
Article in English | MEDLINE | ID: mdl-12711449

ABSTRACT

In photodynamic therapy (PDT), 5-aminiolevulinic acid (5-ALA) applied topically is converted, via the heme cycle, into protoporphyrin IX (PpIX), a photosensitizing agent, which upon excitation with light can induce tumor destruction. Due to its hydrophilic and zwitterionic characteristics, 5-ALA has limited penetration into the skin. More lipophilic 5-ALA ester derivatives are expected to cross stratum corneum more easily than 5-ALA. According to the determination of the partition coefficients of 5-ALA methyl, n-butyl, n-hexyl and n-octyl esters, these compounds showed an increased affinity to the SC, with 5-ALA hexyl ester and 5-ALA-octyl ester having the highest partition coefficients. Our in vitro skin permeation studies demonstrated an increased permeated amount for hexyl-ALA after 6 h of incubation, compared to other esters and 5-ALA. After 6 h, more 5-ALA-hexyl ester and -octyl ester were retained at viable epidermis and dermis than 5-ALA. According to these results, and considering that the conversion of 5-ALA into PpIX occurs preferentially in epidermis, it can be supposed that topical use of ester derivatives with longer chains (C(6) or C(8)) is an interesting proposal to optimize topical 5-ALA-PDT


Subject(s)
Aminolevulinic Acid/analogs & derivatives , Aminolevulinic Acid/pharmacokinetics , Photochemotherapy/methods , Skin Absorption/drug effects , Aminolevulinic Acid/therapeutic use , Animals , Esters , In Vitro Techniques , Male , Mice , Mice, Hairless , Skin Absorption/physiology
SELECTION OF CITATIONS
SEARCH DETAIL